MarketPeel
Insider Trading Intelligence
AW

Amir Weiss

TEVA
CHIEF ACCOUNTING OFFICER · TEVA PHARMACEUTICAL INDUSTRIES LTD · CIK 0001897057
FILING MIX · LIFETIME48%/52%
BUYS
25
SELLS
27
TOTAL VALUE
$1.94M
COMPANIES
1
ACTIVE SINCE
Feb 2022
HOLDINGS NOW
20,016
AVG SELL PX
$19.97
TRADE KIND
SHOWING 52 / 52
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Amir Weiss, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+28.57%+1.37%+0.55%+0.82%+0.59%
14d7+57.14%+0.37%-0.50%+2.00%+2.42%
30d7+14.29%+4.51%+2.63%+1.88%+2.61%
60d7(1 pending)+16.67%+9.37%+2.94%+6.42%+4.12%
90d7(1 pending)+33.33%+9.26%+1.01%+8.24%+3.38%
180d7(1 pending)+0.00%+20.81%+10.83%+9.98%+9.95%
1y7(3 pending)+0.00%+30.21%+18.06%+12.15%+3.90%
2y7(3 pending)+0.00%+118.17%+43.09%+75.08%+77.17%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TEVA · 20,016 shares · as of May 6, 2026
010,67721,35432,03042,7072023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 27 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
10,679$36.00$384.4K20,016May 6, 2026May 7, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
3,53710,613Mar 5, 2026Mar 9, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
3,53730,695Mar 5, 2026Mar 9, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
11,28011,280Mar 4, 2026Mar 6, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
5,65027,158Mar 4, 2026Mar 6, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
5,65011,300Mar 4, 2026Mar 6, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
10,67921,508Mar 4, 2026Mar 6, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
10,6790Mar 4, 2026Mar 6, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
5,17910,829Mar 3, 2026Mar 5, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
5,1795,180Mar 3, 2026Mar 5, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
12,300$30.20$371.5K5,650Dec 16, 2025Dec 18, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
12,300$24.44$300.6K17,950Nov 6, 2025Nov 10, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
3,56630,250Mar 5, 2025Mar 7, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
14,15014,150Mar 5, 2025Mar 7, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
3,5660Mar 5, 2025Mar 7, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
10,67621,034Mar 4, 2025Mar 6, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
5,65026,684Mar 4, 2025Mar 6, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
10,67610,679Mar 4, 2025Mar 6, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
5,65016,950Mar 4, 2025Mar 6, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
5,17910,359Mar 3, 2025Mar 5, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
5,17910,358Mar 3, 2025Mar 5, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
12,635$16.65$210.4K5,179May 16, 2024May 17, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
15,500$16.80$260.4K17,814May 15, 2024May 17, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
3,5643,566Mar 5, 2024Mar 7, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
3,56433,314Mar 5, 2024Mar 7, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
22,60022,600Mar 4, 2024Mar 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
10,67621,355Mar 4, 2024Mar 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
10,67629,750Mar 4, 2024Mar 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
5,17919,074Mar 3, 2024Mar 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
5,17915,538Mar 3, 2024Mar 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
3,2190Feb 28, 2024Mar 1, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
3,21913,895Feb 28, 2024Mar 1, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
31,766$12.37$393.0K10,676Feb 1, 2024Feb 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
1,981.41$9.92$19.7K42,442Aug 4, 2023Aug 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
3,5647,130Mar 5, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
3,56441,204.41Mar 5, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
10,67637,640.41Mar 4, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
2,4060Mar 4, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
10,67632,031Mar 4, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
2,40626,964.41Mar 4, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
20,71720,717Mar 3, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
3,2193,219Feb 28, 2023Mar 2, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
3,21927,777.41Feb 28, 2023Mar 2, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
3,56410,694Mar 5, 2022Mar 8, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
3,56424,558.41Mar 5, 2022Mar 8, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
42,70742,707Mar 4, 2022Mar 8, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
2,40320,994.41Mar 4, 2022Mar 8, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
2,4032,406Mar 4, 2022Mar 8, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
98118,591.41Mar 2, 2022Mar 2, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
9810Mar 2, 2022Mar 2, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
Chief Accounting Officer
3,2196,438Feb 28, 2022Mar 2, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
Chief Accounting Officer
3,21917,610.41Feb 28, 2022Mar 2, 2022View →
Other insiders · TEVA
Loading peer insiders…
About this filer
CIK 0001897057
ROLE
Chief Accounting Officer
PRIMARY
TEVA
COMPANIES
1
ACTIVE SINCE
Feb 2022
MARKETPEEL · /INSIDER/0001897057DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback